The invention concerns innovative Janus nanoparticles designed for the selective delivery of therapeutic agents in the treatment of skin cancer. Thanks to their bipolar structure, these nanoparticles enable precise drug delivery to diseased cells, minimizing systemic toxicity and increasing the effectiveness of targeted therapy.